I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Facon, T
223
results:
Search for persons
X
Format
Online (223)
Mediatypes
Articles (Online) (94)
OpenAccess-fulltext (129)
Languages
french (23)
english (196)
Sorted by: Relevance
Sorted by: Year
?
1
French early nationwide idecabtagene vicleucel chimeric ant..:
Ferment, B.
;
Lambert, J.
;
Caillot, D.
...
British Journal of Haematology. , 2024
Link:
https://doi.org/10.1111/..
?
2
P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) ..:
Weisel, K.
;
Kumar, S.
;
Moreau, P.
...
HemaSphere. 7 (2023) S2 - p. 14-15 , 2023
Link:
https://doi.org/10.1097/..
?
3
P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INE..:
Facon, T.
;
Plesner, T.
;
Usmani, S.
...
HemaSphere. 7 (2023) S2 - p. 18-19 , 2023
Link:
https://doi.org/10.1097/..
?
4
LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASON..:
Crusoe, E
;
Facon, T
;
Moreau, P
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S400 , 2023
Link:
https://doi.org/10.1016/..
?
5
P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF..:
van de Donk, N. W. C. J
;
Popat, R
;
Hulin, C
...
HemaSphere. 6 (2022) - p. 14-15 , 2022
Link:
https://doi.org/10.1097/..
?
6
P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-R..:
Facon, T.
;
Kumar, S. K.
;
Plesner, T.
...
HemaSphere. 6 (2022) - p. 826-827 , 2022
Link:
https://doi.org/10.1097/..
?
7
UPDATED PROGRESSION-FREE SURVIVAL AND DEPTH OF RESPONSE IN ..:
Capra, M
;
Moreau, P
;
Dimopoulos, M
...
Hematology, Transfusion and Cell Therapy. 44 (2022) - p. S249 , 2022
Link:
https://doi.org/10.1016/..
?
8
P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MUL..:
Hasan Bou Issa, L.
;
Fléchon, L.
;
Laine, W.
...
HemaSphere. 6 (2022) - p. 745-746 , 2022
Link:
https://doi.org/10.1097/..
?
9
P907: CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB (KDD) VS ..:
Quach, H.
;
Leleu, X.
;
Mateos, M.-V.
...
HemaSphere. 6 (2022) - p. 798-799 , 2022
Link:
https://doi.org/10.1097/..
?
10
S180: RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANT..:
Hasselbalch Riley, C.
;
Hutchings, M.
;
Yoon, S.-S.
...
HemaSphere. 6 (2022) - p. 81-82 , 2022
Link:
https://doi.org/10.1097/..
?
11
S173: T-CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM TH..:
Dekhtiarenko, I.
;
Lelios, I.
;
Attig, J.
...
HemaSphere. 6 (2022) - p. 74-75 , 2022
Link:
https://doi.org/10.1097/..
?
12
P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN ..:
Nooka, A.
;
Lonial, S.
;
Grosicki, S.
...
HemaSphere. 6 (2022) - p. 829-830 , 2022
Link:
https://doi.org/10.1097/..
?
13
CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZO..:
Quach, H.
;
Nooka, A.
;
Samoylova, O.
...
Hematology, Transfusion and Cell Therapy. 42 (2020) - p. 253-254 , 2020
Link:
https://doi.org/10.1016/..
?
14
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMI..:
Maiolino, A.
;
Moreau, P.
;
Dimopoulos, M.
...
Hematology, Transfusion and Cell Therapy. 42 (2020) - p. 262-263 , 2020
Link:
https://doi.org/10.1016/..
?
15
Isatuximab plus carfilzomib and dexamethasone vs. carfilzom..:
Turgut, M.
;
Moreau, P.
;
Dimopoulos, M.
...
Hematology, Transfusion and Cell Therapy. 42 (2020) - p. 51-52 , 2020
Link:
https://doi.org/10.1016/..
1-15